Clinical meaning
Microcirculation failure refers to the breakdown of perfusion and oxygen delivery at the capillary level — the terminal vascular bed where gas exchange, nutrient delivery, and waste removal actually occur. Even when macrocirculatory parameters (blood pressure, cardiac output, central venous pressure) appear adequate, microcirculatory dysfunction can produce tissue hypoxia, cellular injury, and organ failure. The microcirculation consists of arterioles (resistance vessels controlling flow distribution), capillaries (exchange vessels), and venules (capacitance vessels). Under normal conditions, arteriolar smooth muscle tone is regulated by local metabolic autoregulation (adenosine, CO2, pH, O2 tension), endothelial nitric oxide (NO) production, myogenic response to transmural pressure, and autonomic innervation. In sepsis — the most common cause of microcirculatory failure — endotoxin and inflammatory mediators (TNF-alpha, IL-1, IL-6) activate endothelial cells, causing several pathological changes simultaneously: endothelial glycocalyx degradation (loss of the protective carbohydrate layer that maintains vascular permeability barrier and mechanotransduction), upregulation of adhesion molecules (ICAM-1, VCAM-1, selectins) that promote neutrophil rolling, adhesion, and transmigration, increased endothelial permeability from VE-cadherin disruption allowing capillary leak (third-spacing of fluid, interstitial edema that increases oxygen diffusion distance), microvascular thrombosis from tissue factor expression and impaired thrombomodulin-protein C anticoagulant pathways, and dysregulated NO production — inducible NO synthase (iNOS) generates excessive NO in some vascular beds causing pathological vasodilation while other beds lose endothelial NO synthase (eNOS) activity, creating heterogeneous perfusion with shunting of blood past exchange capillaries. This microcirculatory heterogeneity is the hallmark of septic microcirculation failure: capillaries adjacent to each other may have completely different flow patterns (stopped-flow, intermittent flow, normal flow), producing regional tissue hypoxia despite apparently adequate global oxygen delivery (explaining why central venous oxygen saturation can be normal or elevated while lactate remains high). Mitochondrial dysfunction from oxidative stress further impairs cellular oxygen utilization (cytopathic hypoxia). The clinician recognizes clinical signs of microcirculatory failure (mottled skin, prolonged capillary refill greater than 3 seconds, increased skin temperature gradients between core and periphery, elevated lactate with narrow arteriovenous oxygen difference), understands the limitations of macrocirculatory targets in guiding resuscitation, and integrates perfusion-directed interventions including early fluid resuscitation (restoring preload), vasopressor optimization, and consideration of microcirculation-targeted therapies.